欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/2429/004
药品名称Hydromorphonhydrochlorid-CT 16 mg Hartkapseln, retardiert
活性成分
    • hydromorphone hydrochloride 16.0 mg
剂型Prolonged-release capsule, hard
上市许可持有人CT Arzneimittel, Lengeder Straße 42a, Berlin-Reinickendorf, Germany
参考成员国 - 产品名称Germany (DE)
Hydromorphone hydrochloride Acino 16 mg PRC 01 Hartkapseln, retardiert
互认成员国 - 产品名称
    许可日期2010/10/06
    最近更新日期2018/06/20
    药物ATC编码
      • N02AA03 hydromorphone
    申请类型
    • TypeLevel1:Abridged
    • TypeLevel2:Additional Strength/Form
    • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Prescription Only
    附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase